Meituan
OTC:MPNGY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Meituan
OTC:MPNGY
|
CN |
|
E
|
ExpreS2ion Biotech Holding AB
F:5JD
|
SE |
|
Q
|
QBeyond AG
XHAM:QBY
|
DE |
|
Ipsos SA
F:IPZ
|
FR |
|
Margaret Lake Diamonds Inc
F:M85
|
CA |
|
G
|
Genmab A/S
DUS:GE9
|
DK |
|
P
|
PG&E Corp
SWB:PCG
|
US |
|
S
|
SeaWorld Entertainment Inc
XMUN:W2L
|
US |
|
B
|
Beacon Minerals Ltd
ASX:BCN
|
AU |
|
F
|
Fortis Inc
SWB:12F
|
CA |
|
Willow Biosciences Inc
F:3D7
|
CA |
Wall St Price Targets
MPNGY Price Targets Summary
Meituan
According to Wall Street analysts, the average 1-year price target for
MPNGY is 30.34 USD with a low forecast of 14.59 USD and a high forecast of 79.37 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MPNGY's stock price target?
Price Target
30.34
USD
According to Wall Street analysts, the average 1-year price target for
MPNGY is 30.34 USD with a low forecast of 14.59 USD and a high forecast of 79.37 USD.
What is the Revenue forecast for Meituan?
Projected CAGR
10%
Over the last 9 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Meituan?
Projected CAGR
12%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 38%. The projected CAGR for the next 8 years is 12%.